Healthcare

Image

Global Transdermal Patches Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Jul 2023
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Transdermal Patches Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 7132.45 Million
Diagram Market Size (Forecast Year) USD 10465.37 Million
Diagram CAGR %

Global Transdermal Patches Market, By Product (Single-Layer Drug-In-Adhesive, Multi-Layer Drug-In-Adhesive, Matrix, Reservoir, Vapor, and Others), Type (Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Oxybutynin Transdermal Patch, and Others), Application (Cardiovascular Disorder, Central Nervous System Disorders (CNS), Pain Management/ Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, Nicotine Cessation, Hormonal Therapy/ Disorders, Dermatology, and Others), Technology (Electric Current, Mechanical Arrays, Thermal Ablation, Chemical Enhancers, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End-user (Home Care Settings, Hospitals, and Clinics) – Industry Trends and Forecast to 2030.

Transdermal Patches Market Analysis and Size

The type of adhesive patches known as transdermal patches is therapeutic. By utilizing transdermal technology and the diffusion technique, they assist in delivering a predetermined dose of medication inside the body. Over time, the medication eventually enters the bloodstream. Transdermal patches are used to treat several illnesses, such as migraines, diabetes, Alzheimer’s, cardiac, and hormonal disorders. Given smoking-related illnesses claim the lives of 48,000 Canadians every year. Numerous other people experience chronic illnesses. 15% of Canadians continue to smoke despite public health initiatives and prevention programs, which have increased drug accessibility and eliminated by the use of patches thus, the introduction of novel, cutting-edge medications like transdermal patches has accelerated the market's expansion.

Data Bridge Market Research analyses that the transdermal patches market, which was USD 7,132.45 million in 2022, would rocket up to USD 10,465.37 million by 2030, and is expected to undergo a CAGR of 4.9% during the forecast period.“Single-Layer Drug-In-Adhesive” dominates the product segment of the transdermal patches market owing to the high demand of this type of products. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Transdermal Patches Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Product (Single-Layer Drug-In-Adhesive, Multi-Layer Drug-In-Adhesive, Matrix, Reservoir, Vapor, and Others), Type (Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Oxybutynin Transdermal Patch, and Others), Application (Cardiovascular Disorder, Central Nervous System Disorders (CNS), Pain Management/ Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, Nicotine Cessation, Hormonal Therapy/ Disorders, Dermatology, and Others), Technology (Electric Current, Mechanical Arrays, Thermal Ablation, Chemical Enhancers, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End user (Home Care Settings, Hospitals, and Clinics)

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America

Market Players Covered

AdhexPharma (France) ProSolus, Inc (U.S.), Tapemark (U.S.), tesa Tapes (India) Pvt. Ltd. (Germany), Nitto Denko Corporation (Japan), Noven Pharmaceuticals, Inc (U.S.), LTS Lohmann Therapie-Systeme AG (Germany), Medherant Limited (U.K.), Corium, Inc. (U.S.), Bayer AG (Germany), Novartis AG (Switzerland), Antares Pharma (U.S.), Abbott. (U.S.), Medipatch, Inc. (U.S.), Mylan N.V. (U.S.), Acrux Limited (Australia), Sparsha Pharma International Pvt Ltd (India), Bliss GVS Pharma (India), Johnson & Johnson (U.S.), and Informa PLC (U.K.) among others

Market Opportunities

  • Growth in the deployment of advanced technologies
  • Increasing number of healthcare and pharmaceutical facilities globally
  • Rising research and development opportunities

Market Definition

A transdermal patch is a medicated adhesive patch applied to the skin to deliver a specific medication dosage into the bloodstream. Transdermal drug delivery differs from other methods of medication delivery (such as oral, topical, intravenous, or intramuscular) due to the controlled release of the medication into the patient that the patch provides, typically through a porous membrane covering a reservoir of drugs or through body heat melting thin layers of medicine embedded in the adhesive.

Transdermal Patches Market Dynamics

Drivers

  • Smokers' population growth in the area accelerates the growth

The region's growing smoking population is anticipated to increase demand for nicotine transdermal patches, boosting market growth. For instance, according to information released by the CDC in March 2022, approximately 34.0% of high school students (5.22 million) and 11.3% of middle school students (1.34 million) said they had ever used a tobacco product, such as cigarettes, cigars, smokeless tobacco, hookahs, pipe tobacco, heated tobacco products, nicotine pouches, or bidis (small brown cigarettes wrapped in a leaf). Additionally, among high school and middle school students, e-cigarettes are the most frequently used tobacco product from the same source, followed by cigarettes, cigars, smokeless tobacco, hookahs, nicotine pouches, heated tobacco products, and pipe tobacco.

  • Increased cancer rates allow for growth

Breast and prostate cancer incidence are rising, which will likely significantly speed up market growth. For instance, the GLOBOCAN 2020 report states that Mexico reported 195,499 cancer cases in 2020, with breast and prostate cancers being the most prevalent. According to GLOBOCAN 2020, there will be 254,665 new cancer cases in Mexico by 2030 and 323,432 cases by 2040. Thus, the rising incidence of cancer in the population is anticipated to spur demand for transdermal patches containing medication nanoparticles that reduce cancer therapy-related pain.

  • Growing investment in healthcare facilities

Surging focus on improving the condition of healthcare facilities and improving the overall healthcare infrastructure is another important factor fostering market growth. The rising number of partnerships and strategic collaborations between the public and private players about funding and application of new and improved technology further creates lucrative market opportunities.  

Opportunities

  • Growing technological developments accelerate market expansion

Growing advantages over oral and ingestible medications, rising non-invasive and painless medication administration, rising adoption of a variety of strategies, including product innovation, growing product launches, and approvals, rising research and development investment for advancements in transdermal patches, merger and acquisition as a crucial strategy, and rising technological advances in transdermal drug delivery systems are all major drivers of the market.

  • Growing partnerships and collaborations create expansion

Transdermal patches will have opportunities in the market due to expanding self-administration and home care drug delivery systems, as well as growing pharmaceutical company-drug delivery company partnerships. For instance, in 2021, BASF unveiled "Sacred Patch," a fresh active skincare ingredient that might enhance psychological well-being. Similarly, the USFDA approved an abbreviated new drug application (ANDA) from Amneal Pharmaceuticals Inc. To encourage foreign tourists to "Be a part of the solution," local government organizations worked with the General Communication Coordination (CGC).

Restraints/Challenges

  • Increasing technical barriers can restrict the growth

Although increasing technical barriers related to skin irritation and permeability will present additional challenges to the growth of the transdermal patches market during the forecast period mentioned above, the main factors limiting the market growth are the increasing inability of the skin to absorb a wide range of medications and the rising incidence of contact dermatitis or other skin infections at the site of application. Factors that can prevent the expansion include the skin's growing inability to absorb various medications and the elevated risk of contact dermatitis or other skin conditions at the application site.

  • Strict regulatory approval by government regulatory bodies limits the market growth

Transdermal skin patch market growth is being hampered by the government regulatory bodies' strict regulatory approval. The laws governing biologics, medicines, and medical devices of which may cause the regulatory authority enforces adverse user reactions. For instance, before approving the TDDS for use on the market, the Food and Drug Administration (FDA) requires the TDDS to undergo a series of tests, including biomechanical testing, animal testing, and clinical trials. The process takes time and could delay the introduction of TDDS into the market, losing the first-mover advantage and limiting the market's expansion for transdermal skin patches.

This transdermal patches market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the transdermal patches market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In 2022, Adlarity (donepezil transdermal system) from Corium became available in the U.S. with a prescription. A once-weekly patch called Adlarity delivers consistent doses of donepezil under the skin. Patients with mild, moderate, or severe Alzheimer's-related dementia may be treated with it
  • In 2022, The Luye Pharma Group reported that the National Medical Products Administration (NMPA) of China's Center for Drug Evaluation (CDE) had approved the Marketing Authorization Application (MAA) for the company's investigational Rivastigmine Twice Weekly Transdermal Patch, which was indicated for the treatment of mild to moderate symptoms of Alzheimer's disease.

Global Transdermal Patches Market Scope

The transdermal patches market is segmented on the basis of product, type, application, technology, distribution channel, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Single-Layer Drug-In-Adhesive
  • Multi-Layer Drug-In-Adhesive
  • Matrix
  • Reservoir
  • Vapor
  • Others

Type

  • Fentanyl Transdermal Patch
  • Nicotine Transdermal Patch
  • Buprenorphine Transdermal Patch
  • Clonidine Transdermal Patch
  • Oxybutynin Transdermal Patch
  • Others

Application

  • Cardiovascular Disorder
  • Central Nervous System Disorders (CNS)
  • Pain Management/ Relief
  • Smoking Reduction and Cessation Aid
  • Overactive Bladder
  • Nicotine Cessation
  • Hormonal Therapy/ Disorders
  • Dermatology
  • Others

Technology

  • Electric Current
  • Mechanical Arrays
  • Thermal Ablation
  • Chemical Enhancers
  • Others

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

End Users

  • Home Care settings
  • Hospitals
  • Clinics

Transdermal Patches Market Regional Analysis/Insights

The transdermal patches market is analysed and market size insights and trends are provided by country, product, type, application, technology, distribution channel, and end user as referenced above.

The countries covered in the transdermal patches market  report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.

North America is expected to dominate the market because of the strong base of healthcare facilities, the strong presence of major players in the market, and the rising number of research activities in this region.

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in healthcare facilities, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The transdermal patches market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Transdermal patches Market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Transdermal patches Market. The data is available for historic period 2010-2020.

Competitive Landscape and Transdermal patches Market Share Analysis

The transdermal patches market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to transdermal patches market.

Some of the major players operating in the transdermal patches market are:

  • AdhexPharma (France)
  • ProSolus, Inc (U.S.)
  • Tapemark (U.S.)
  • tesa Tapes (India) Pvt. Ltd. (Germany)
  • Nitto Denko Corporation. (Japan)
  • Noven Pharmaceuticals, Inc (U.S.)
  • LTS Lohmann Therapie-Systeme AG (Germany)
  • Medherant Limited (U.K.)
  • Corium, Inc. (U.S.)
  • Bayer AG (Germany)
  • Novartis AG (Switzerland)
  • Antares Pharma (U.S.)
  • Abbott. (U.S.)
  • Medipatch, Inc. (U.S.)
  • Mylan N.V. (U.S.)
  • Acrux Limited (Australia)
  • Sparsha Pharma International Pvt Ltd (India)
  • Bliss GVS Pharma. (India)
  • Johnson & Johnson (U.S.)
  • Informa PLC (U.K.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Transdermal Patches Market will be worth USD 10,465.37 million by 2030.
The Transdermal Patches Market Growth Rate is 4.9% during the forecast period.
The Growing investment in healthcare facilities, Increased cancer rates allow for growth, and Smokers' population growth in the area accelerates the growth are the Growth drivers of the Transdermal Patches Market.
The product, type, application, technology, distribution channel, and end-user are the factors on which the Transdermal Patches Market research is based.
The major companies in the Transdermal Patches Market are AdhexPharma (France) ProSolus, Inc (U.S.), Tapemark (U.S.), tesa Tapes (India) Pvt. Ltd. (Germany), Nitto Denko Corporation (Japan), Noven Pharmaceuticals, Inc (U.S.), LTS Lohmann Therapie-Systeme AG (Germany), Medherant Limited (U.K.), Corium, Inc. (U.S.), Bayer AG (Germany), Novartis AG (Switzerland), Antares Pharma (U.S.), Abbott. (U.S.), Medipatch, Inc. (U.S.), Mylan N.V. (U.S.), Acrux Limited (Australia), Sparsha Pharma International Pvt Ltd (India), Bliss GVS Pharma (India), Johnson & Johnson (U.S.), and Informa PLC (U.K.).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials